Key Takeaways From JNJ's (JNJ) Q4 Earnings Presentation

Johnson & Johnson (JNJ) reported fourth-quarter and full-year 2024 results on Jan 23. The drug and medical devices giant beat the Zacks Consensus Estimate for both earnings as well as sales in the fourth quarter.In August, J&J completely separated its Consumer Health business into a newly listed company called Kenvue (KVUE) , which now operates as a separate and fully independent company.After completion of the exchange offer, J&J now has a 9.5% stake (approximately 180 million shares) in Kenvue’s common st ...